TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.

Ronan Flippot et al.PubMed ↗Publisher ↗

No numbers read from the abstract.